MedTrace Logo

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

NCT06167356 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2023-12-12

No results posted yet for this study

Summary

A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.

Conditions

  • Non Muscle Invasive Bladder Cancer
  • Non-Muscle Invasive Bladder Neoplasms
  • Non-Muscle Invasive Bladder Urothelial Carcinoma
  • Bladder Cancer
  • Bladder Disease
  • Bladder Neoplasm
  • Bladder Urothelial Carcinoma
  • Bladder Cancer Stage I, With Cancer in Situ
  • Bladder Cancer Recurrent
  • Bladder Urothelial Carcinoma in Situ
  • Bladder Urothelial Dysplasia

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • Francesco Montorsi, MD · IRCCS Ospedale San Raffaele

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-27
Primary Completion
2063-11-27
Completion
2063-11-27

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06167356 on ClinicalTrials.gov